MORRISVILLE, N.C., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Syneos Health® (SYNH), the only fully integrated biopharmaceutical solutions organization combining a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), will release its third quarter 2019 financial results on Thursday, October 31, 2019, prior to its earnings call at 8:00 a.m. ET.
Participants may access the conference call live via webcast on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com. To participate via telephone, please dial +1 877 930 8058 within the United States or +1 253 336 7551 outside the United States approximately 15 minutes prior to the scheduled start time. The conference ID for the call is 6646644.
A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 1:00 p.m. on October 31. In addition, an audio replay will be available for one week following the call and will be accessible by dialing +1 855 859 2056 within the United States or +1 404 537 3406 outside the United States. The replay ID is 6646644.
About Syneos Health
Syneos Health® (SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com.
|Investor Relations Contact:||Press/Media Contact:|
|Ronnie Speight||Danielle DeForge|
|Senior Vice President, Investor Relations||Executive Director, External Communications|
|+1 919 745 2745||+1 781 425 2624|